Philadelphia Magazine Names 72 Temple and Fox Chase Cancer Center Physicians ‘Top Doctors in Cancer Care’

PHILADELPHIA (October 19, 2020)—Philadelphia magazine has named 72 Temple and Fox Chase Cancer Center physicians to its “Top Doctors in Cancer Care” list for 2020. Physicians on the list were nominated by their professional peers.

“Temple Health is proud to have so many of its physicians across 25 different specialties selected for Philadelphia magazine’s ‘Top Doctors in Cancer Care,’ said Michael A. Young, MHA, FACHE, president and CEO of Temple University Health System. “Temple and Fox Chase Cancer Center physicians provide complete care from diagnosis through life after treatment for all cancers, and their representation on this list is further proof of the quality of care provided by our renowned clinical team.”

“We are honored that so many of our Temple and Fox Chase physicians have been recognized in Philadelphia magazine for their expertise in cancer care,” said Richard I. Fisher, MD, president and CEO of Fox Chase Cancer Center. “Their outstanding work, particularly during these challenging times, reflects proudly on our institution and all who serve our mission of prevailing over cancer.”

The Temple Health doctors on this year’s “Top Doctors” list represent the following 25 specialties: Thoracic and Cardiac Surgery; Radiation Oncology; Medical Oncology; Gynecologic Oncology; Breast Surgery; Urology and Urologic Oncology; Psychiatry; Pain Medicine; Pathology; Surgery; Hematology/Oncology; Pulmonary Disease; Endocrinology, Diabetes, and Metabolism; Otolaryngology; Cardiovascular Disease; Diagnostic Radiology; Gastroenterology; Plastic and Reconstructive Surgery; Dermatology; Vascular and Interventional Radiology; Urology; Colon and Rectal Surgery; Neurological Surgery; Plastic Surgery; and Nuclear Medicine.

The 2020 “Top Doctors” are:

  • Abbas El-Sayed Abbas, MD, MS, FACS – Thoracic and Cardiac Surgery
  • Penny R. Anderson, MD — Radiation Oncology (FCCC)
  • Jessica R. Bauman, MD — Medical Oncology (FCCC)
  • Cynthia A. Bergman, MD — Gynecologic Oncology (FCCC)
  • Richard J. Bleicher, MD, FACS — Breast Surgery (FCCC)
  • Michael E. Bromberg, MD, PhD – Hematology
  • David Y.T. Chen, MD, FACS — Urology and Urologic Oncology (FCCC)
  • Emmie I. Chen, MD — Psychiatry (FCCC)
  • Christina S. Chu, MD — Gynecologic Oncology (FCCC)
  • Marcin A. Chwistek, MD, FAAHPM — Pain Medicine (FCCC)
  • Gary S. Cohen, MD – Vascular and Interventional Radiology
  • Harry S. Cooper, MD — Pathology (FCCC)
  • Paul G. Curcillo II, MD, FACS — Surgery (FCCC)
  • John M. Daly, MD, FACS – Surgery
  • Mary B. Daly, MD, PhD, FACP — Medical Oncology (FCCC)
  • Martin J. Edelman, MD — Medical Oncology (FCCC)
  • Hormoz Ehya, MD — Pathology (FCCC)
  • Cherie P. Erkmen, MD – Thoracic and Cardiac Surgery
  • Daniel D. Eun, MD – Urology
  • Jeffrey M. Farma, MD, FACS — Surgery (FCCC)
  • Richard I. Fisher, MD — Hematology/Oncology (FCCC)
  • Henry C. Fung, MD, FACP, FRCPE — Hematology/Oncology (FCCC)
  • Lori J. Goldstein, MD, FASCO — Medical Oncology (FCCC)
  • Richard E. Greenberg, MD, FACS — Urology and Urologic Oncology (FCCC)
  • Alan D. Haber, MD, FCCP — Pulmonary Disease (FCCC)
  • Michael J. Hall, MD, MS — Medical Oncology (FCCC)
  • Eman A. Hamad, MD, FACC, FHFSA – Cardiovascular Disease
  • Shelly B. Hayes, MD — Radiation Oncology (FCCC)
  • Enrique Hernandez, MD – Gynecologic Oncology
  • Stephen J. Heller, MD – Gastroenterology
  • Eric M. Horwitz, MD, FABS, FASTRO — Radiation Oncology (FCCC)
  • Karen L. Houck, MD, FACOG – Gynecologic Oncology
  • Stephanie A. King, MD — Gynecologic Oncology (FCCC)
  • Christian A. Koch, MD, PhD, FACP, MACE — Endocrinology, Diabetes, and Metabolism (FCCC)
  • Benjamin Krevsky, MD, MPH – Gastroenterology
  • Alexander Kutikov, MD, FACS — Urology and Urologic Oncology (FCCC)
  • Jeffrey C. Liu, MD, FACS ¬¬— Otolaryngology (FCCC)
  • Christopher J. Manley, MD — Pulmonary Disease (FCCC)
  • Gina M. Mantia-Smaldone, MD — Gynecologic Oncology (FCCC)
  • Steven J. Mattleman, MD, FACC — Cardiovascular Disease (FCCC)
  • Michael J. Metro, MD – Urology
  • Barton N. Milestone, MD — Diagnostic Radiology (FCCC)
  • Juhi Mittal, MD – Medical Oncology
  • Curtis T. Miyamoto, MD – Radiation Oncology
  • Jack H. Mydlo, MD – Urology
  • Minhhuyen T. Nguyen, MD, AGAF, FACP — Gastroenterology (FCCC)
  • Rosaleen B. Parsons, MD, FACR, FSAR — Diagnostic Radiology (FCCC)
  • Sameer A. Patel, MD, FACS — Plastic and Reconstructive Surgery (FCCC)
  • Roman V. Petrov, MD – Thoracic and Cardiac Surgery
  • Matthew M. Philp, MD – Colon and Rectal Surgery
  • Elizabeth R. Plimack, MD, MS — Medical Oncology (FCCC)
  • Joseph V. Queenan, MD – Neurological Surgery
  • Adam C. Reese, MD – Urology
  • John A. Ridge, MD, PhD, FACS — Surgery (FCCC)
  • Howard M. Ross, MD, FACS, FASCRS – Colon and Rectal Surgery
  • Stephen C. Rubin, MD — Gynecologic Oncology (FCCC)
  • Anthony F. Santoro, MD — Dermatology (FCCC)
  • Deric C. Savior, MD – Medical Oncology
  • Cecelia E. Schmalbach, MD, MSc, FACS – Otolaryngology
  • Elin R. Sigurdson, MD, PhD, FACS, FRCS — Surgery (FCCC)
  • Mark L. Sobczak, MD, FACR — Radiation Oncology (FCCC)
  • Stacey Su, MD — Thoracic and Cardiac Surgery (FCCC)
  • Jeffrey L. Tokar, MD, FASGE, AGAF — Gastroenterology (FCCC)
  • Neal Topham, MD, FACS — Plastic Surgery (FCCC)
  • John M. Travaline, MD – Pulmonary Disease
  • Robert G. Uzzo, MD, MBA, FACS — Urology and Urologic Oncology (FCCC)
  • Margaret von Mehren, MD — Medical Oncology (FCCC)
  • Michael W. Weaver, MD – Neurological Surgery
  • David S. Weinberg, MD, MSc — Gastroenterology (FCCC)
  • Stephanie E. Weiss, MD, FASTRO — Radiation Oncology (FCCC)
  • Jennifer S. Winn, MD, MS — Medical Oncology (FCCC)
  • Jian Q. (Michael) Yu, MD, FACNM, FRCPC — Nuclear Medicine (FCCC)

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427